Learn

PharmaTher Achieves Historic Ketamine FDA Approval After Third Attempt

PharmaTher has secured FDA approval for its ketamine product KETARx, which is specifically for surgical pain management.

Read More

Arizona Launches First Trial Using Whole Psilocybin Mushrooms for PTSD Treatment

Twenty four Arizonans living with post traumatic stress disorder will participate in a groundbreaking study next month.

Read More

GLP-1 Providers Can Now Drive New Revenue Streams Through Diagnostic Bundling

The compounded GLP-1 market has become fiercely competitive. Most clinics compete on price and speed. Mindful Labs wants to change

Read More

From Fringe to Mainstream: Psychedelic Retreats Reshape the Wellness Travel Market

Psychedelic retreats have moved from the fringes of wellness culture into the full blown mainstream travel market.

Read More

Magic Mushrooms Move Mainstream as Science and Policy Lag Behind

Psilocybin is moving into the mainstream faster than science and policy can keep up. Will this interest in move the

Read More

FDA Grants Priority Vouchers to Three Psychedelic Drug Programs

The FDA's decision could deliver the first psychedelic medicine approved by the FDA as soon as this summer.

Read More

MindMetrix Wants to Fix the First Step in Mental Health Care: The Diagnosis

A Chicago company is betting that better mental health treatment starts with a better assessment. MindMetrix has built a comprehensive

Read More

“Nobody Wants A Synthetic-Only Future”: Filament Health Is Formulating Natural Psilocybin And Standardizing Ayahuasca

Filament Health CEO Ben Lightburn discusses the challenges of producing natural extracts for psychedelic therapy.

Read More

At Denver’s Microdose Mondays, Magic Mushrooms are a Legal Gift

In Denver, Microdose Mondays classes teach folks about psilocybin mushrooms, and gifts them a month's worth of microdoses. Here's why.

Read More

Albino Penis Envy Mushrooms: Potency, Effects, and Legal Status (2026)

Albino Penis Envy is a leucistic Penis Envy variant — ~0.9-1.1% psilocybin by weight, roughly 50-80% stronger than common cubensis.

Read More

Explore Psychedelic Therapy Regions